These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 10454454

  • 1. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K, Morishita R, Moriguchi A, Tomita N, Yo Y, Nishii T, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [Abstract] [Full Text] [Related]

  • 2. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
    Matsumoto K, Morishita R, Tomita N, Moriguchi A, Komai N, Aoki M, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Heart Vessels; 2003 Mar; 18(1):18-25. PubMed ID: 12644877
    [Abstract] [Full Text] [Related]

  • 3. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N, Moriguchi A, Morishita R, Kida I, Tomita N, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [Abstract] [Full Text] [Related]

  • 4. The angiotensin I-converting enzyme inhibitor, cilazapril inhibits the platelet-derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats.
    Yamauchi T, Ogura T, Oishi T, Omiya T, Ota Z.
    Ren Physiol Biochem; 1995 Dec; 18(5):237-45. PubMed ID: 8869081
    [Abstract] [Full Text] [Related]

  • 5. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
    Nakamura T, Honma H, Ikeda Y, Kuroyanagi R, Takano H, Obata J, Sato T, Kimura H, Yoshida Y, Tamura K.
    Blood Press Suppl; 1994 Dec; 5():61-6. PubMed ID: 7889203
    [Abstract] [Full Text] [Related]

  • 6. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F.
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [Abstract] [Full Text] [Related]

  • 7. Effects of cilazapril on the retinal vessels in spontaneously hypertensive rats: corrosion cast and scanning electron microscopic study.
    Bhutto IA, Amemiya T.
    Life Sci; 1999 Mar; 64(3):PL27-39. PubMed ID: 10027753
    [Abstract] [Full Text] [Related]

  • 8. [The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].
    Gu Y, Chen J, Yang H, Zhu W, Lin F, Zhu C, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Jan 10; 82(1):10-3. PubMed ID: 11953118
    [Abstract] [Full Text] [Related]

  • 9. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats.
    Clozel M, Kuhn H, Hefti F.
    Hypertension; 1990 Nov 10; 16(5):532-40. PubMed ID: 2146221
    [Abstract] [Full Text] [Related]

  • 10. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y.
    Hypertension; 1998 Sep 10; 32(3):467-72. PubMed ID: 9740612
    [Abstract] [Full Text] [Related]

  • 11. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
    Castro-Moreno P, Pardo JP, Hernández-Muñoz R, López-Guerrero JJ, Del Valle-Mondragón L, Pastelín-Hernández G, Ibarra-Barajas M, Villalobos-Molina R.
    Auton Autacoid Pharmacol; 2012 Oct 10; 32(3 Pt 4):61-9. PubMed ID: 22994939
    [Abstract] [Full Text] [Related]

  • 12. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
    Nakano N, Morishita R, Moriguchi A, Nakamura Y, Hayashi SI, Aoki M, Kida I, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1998 Sep 10; 32(3):444-51. PubMed ID: 9740609
    [Abstract] [Full Text] [Related]

  • 13. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
    Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, Inagami T.
    J Hypertens; 2000 Sep 10; 18(9):1247-55. PubMed ID: 10994756
    [Abstract] [Full Text] [Related]

  • 14. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
    Touyz RM, Endemann D, He G, Li JS, Schiffrin EL.
    Hypertension; 1999 Jan 10; 33(1 Pt 2):366-72. PubMed ID: 9931131
    [Abstract] [Full Text] [Related]

  • 15. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K, Saito T, Yasujima M, Sato T, Abe K.
    J Hypertens; 1995 Dec 10; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
    Benter IF, Yousif MH, Al-Saleh FM, Raghupathy R, Chappell MC, Diz DI.
    J Cardiovasc Pharmacol; 2011 May 10; 57(5):559-67. PubMed ID: 21326110
    [Abstract] [Full Text] [Related]

  • 17. Effect of amlodipine and cilazapril treatment on platelet Ca2+ handling in spontaneously hypertensive rats.
    Oshima T, Ono N, Ozono R, Higashi Y, Ishida M, Ishida T, Miho N, Nakashima H, Yano Y, Kambe M.
    Hypertens Res; 2003 Nov 10; 26(11):901-6. PubMed ID: 14714582
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.
    Hypertension; 2000 Jan 10; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
    Tanaka M, Umemoto S, Kawahara S, Kubo M, Itoh S, Umeji K, Matsuzaki M.
    Hypertens Res; 2005 Jan 10; 28(1):67-77. PubMed ID: 15969257
    [Abstract] [Full Text] [Related]

  • 20. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
    Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei-Kim, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Circulation; 2000 Jul 11; 102(2):246-52. PubMed ID: 10889138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.